Search clinical trials for: NFC-1

Total 15387 results

Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

22q11.2 Deletion Syndrome

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
UPM Biomedicals
University of Helsinki

Completed

NFC Dressing for Skin Graft Donor Sites (FibDexHBC)

Skin Transplantation

Finland
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Children's Hospital of Philadelphia; Thomas Jefferson University; Pearson/Clinical...

Completed

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder (NFC1-GREAT)

Attention-deficit Hyperactivity Disorder (ADHD)

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
University of Oklahoma
National Cancer Institute (NCI)

Recruiting

Advanced or Recurrent Solid Tumors Treated With SHetA2 (Okgyn1)

Solid Tumor, Adult

United States
Massachusetts General Hospital
Patient-Centered Outcomes Research Institute

Not yet recruiting

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Neurofibromatosis 1

United States
Nocion Therapeutics

Completed

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

Refractory Chronic Cough

United States
Puerta de Hierro University Hospital

Completed

Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia (CME-LEM4)

Post-Traumatic Syringomyelia
NFL Biosciences SAS

Recruiting

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy (CESTO2)

Smoking Cessation | Nicotine Dependence

France
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; National Cancer Institute (NCI); Medarex

Completed

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

Melanoma (Skin)

United States
Novartis Pharmaceuticals

Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Leukaemia, Lymphocytic, Chronic

India, United Kingdom, Netherlands, Canada, Germany, Greece, Italy, Poland, Russian Federation, Spain, Taiwan, Thailand, United States, Brazil, Bulgaria, Mexico, Romania, Ukraine
Nestlé

Completed

Probiotic BL NCC 2705 and Gluten Sensitivity

Celiac Disease | Non-celiac Gluten Sensitivity

Netherlands
NovaBay Pharmaceuticals, Inc.
Novum Pharmaceutical Research Services; International Dermatology Research,...

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Impetigo

Dominican Republic
Khushi Baby Inc.
Johns Hopkins Bloomberg School of Public Health; Indian Institute of Health... and other collaborators

Unknown

Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India

DTP Vaccine Series Completion
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Completed

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis (ENACT)

Venous Thrombosis (Disorder)

United States
HRH Pharmaceuticals Limited
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaborators

Completed

Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)

COVID-19

Brazil
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; National Cancer Institute (NCI); Medarex

Completed

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Melanoma (Skin)

United States
HRH Pharmaceuticals Limited
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaborators

Completed

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

COVID-19

Brazil
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
NovaBay Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients

Asymptomatic Bacteriuria

United States
Nobelpharma

Completed

An Additional Study of NPC-22 in Healthy Adult Males

Safety and Pharmacokinetics

Japan
Nobelpharma

Completed

A Study of NPC-22 in Healthy Adult Males

Healthy Adult Subjects

Japan
GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg

Healthy

Korea, Republic of
GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg

Healthy

Korea, Republic of
NewLink Genetics Corporation

Terminated

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (D-1MT)

Melanoma | Breast Cancer | Pancreatic Cancer | Lung Cancer | Solid Tumors

United States
University of Maryland, Baltimore
National Institute on Aging (NIA); Penn State University

Recruiting

Implementation of Function Focused Care in Acute Care

Dementia | Hospitalization | Acute Medical Event

United States
Nobelpharma

Completed

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Cytomegalovirus Disease

United States, Japan
DePuy International

Terminated

A Study to Compare the Press Fit Condylar (P.F.C.) Sigma Rotating-platform High-flexion (RP-F) Versus the Press Fit Condylar (P.F.C.) Sigma Rotating-platform (RP) Knee Implants

Knee Osteoarthritis

Spain, United Kingdom
Grifols Therapeutics LLC

Completed

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

Alpha 1-Antitrypsin Deficiency

Denmark, Sweden, United Kingdom
BestBrain Ltd.

Unknown

BestBrain Evaluation of Cognitive Memory & Executive-Function (BECOME)

Mild Cognitive Impairment

Israel
DePuy International

Terminated

P.F.C. Sigma Fixed Versus P.F.C. RP Mobile Bearing Total Knee Systems

Osteoarthritis, Knee

United Kingdom
Rush University Medical Center
Pamlab, Inc.

Completed

Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints

Subjective Memory Loss in Older Persons

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Recruiting

CNS10-NPC for the Treatment of RP

Retinitis Pigmentosa

United States
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

Head and Neck Carcinoma

United States
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Optimapharm

Withdrawn

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Gastrointestinal Cancer

Germany
Boehringer Ingelheim

Terminated

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Ewha Womans University

Completed

Comparison of Nonposterior- and Posterior-Stabilized Mobile-Bearing Total Knee Arthroplasty

Osteoarthritis

Korea, Republic of
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Recruiting

Pilot Study of the Parental Friendship Coaching+ Program for Families of Children With Attention-deficit/Hyperactivity Disorder (PFC+)

Depression | ADHD

Canada
China Medical University, China

Completed

the Effect of Trans-nasal Fixation of Endotracheal Tubes for Prone Ventilation (Trans)

Prone Craniotomy | Endotracheal Intubation Fixation

China
NuCana plc

Terminated

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

Ovarian Cancer

United States, United Kingdom
Cochlear
numerics data GmbH

Completed

Comparison of the New Fitting Method Cochlear Nucleus Fitting Software (NFS) With the Established Fitting Method Cochlear Nucleus Custom SoundTM Suite (CSS)

Hearing Loss

Germany, Switzerland
Tohoku University

Completed

Pharmacokinetic Study on N-acetylneuraminic Acid

Hereditary Inclusion Body Myopathy | Nonaka Myopathy

Japan
Boston Children's Hospital
Patient-Centered Outcomes Research Institute; Pediatric Research in Inpatient...

Recruiting

The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

Communication

United States
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

United Kingdom
Nobelpharma

Completed

Efficacy Confirmation Study of NPC-09

GNE Myopathy | Nonaka Disease | Distal Myopathy With Rimmed Vacuoles (DMRV) | Hereditary Inclusion Body Myopathy (hIBM)

Japan
University Hospital, Clermont-Ferrand
MEDIS Laboratory; QUAPA; ENTeRisk

Recruiting

Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants (CortECS)

Premature Birth | Necrotizing Enterocolitis

France

Search clinical trials for: NFC-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations